Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.00
Bid: 488.00
Ask: 488.40
Change: 2.80 (0.58%)
Spread: 0.40 (0.082%)
Open: 485.20
High: 489.60
Low: 485.20
Prev. Close: 485.20
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change - Replacement

10 Mar 2023 09:31

RNS Number : 5816S
Phoenix Group Holdings PLC
10 March 2023
 

LEI: 2138001P49OLAEU33T68

 

This announcement replaces the Board Changes announcement (RNS No: 4972S) made today at 9am. Today's date is 10 March 2023 all other details remain unchanged.

 

10 March 2023

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") announces that Kory Sorenson will retire from the Board on 30 June 2023 after serving 9 years as an Independent Non- Executive Director. Kory has served as Chair of the Remuneration Committee since 11 May 2017 and as a member of the Nomination, Risk and Sustainability Committees.

 

Kory will be succeeded as Chair of the Remuneration Committee by Nicholas Shott with effect from the conclusion of the Annual General Meeting on 4 May 2023, subject to shareholder and regulatory approvals.

 

This announcement is made pursuant to LR 9.6.11 of the Listing Rules.

 

The Phoenix Board is pleased to announce that Mark Gregory will be appointed as an independent Non-Executive Director and a member of the Risk Committee with effect from 1 April 2023.

 

Mark is a former FTSE 100 Chief Financial Officer and divisional Chief Executive Officer ("CEO") with a breadth of experience across financial services and retail. He has a deep knowledge and understanding of the Insurance industry gained from a near 20 year career at Legal & General (L&G), as well as non-executive roles on FTSE 100 and 250 Boards.

 

He has extensive experience in both life and general insurance, audit, regulation, investment management and M&A with recent executive experience at L&G and Merian Global Investors. Mark is currently a Non-Executive Director at Direct Line Insurance Group plc where he is also their Chair of the Risk Committee and a Member of the Audit, Remuneration and Investment Committees.

 

Mark was a Non-Executive Director, Chair of the Remuneration Committee and a Member of the Audit and Nomination Committees at Entain plc.  Mark was also CEO of Merian Global Investors from January 2019 to August 2020.

 

Commenting on the changes, Alastair Barbour, Chair of Phoenix Group said:

"I would like to thank Kory for the significant contribution she has made to Phoenix during her time on the Board, in particular as Chair of the Remuneration Committee for almost 6 years."

 

"We are delighted that Mark has agreed to join the Board of Phoenix Group Holdings plc. He is an accomplished executive with significant experience in the financial services, insurance and investment management sectors and will bring additional capability/skills as Phoenix pursues its long-term strategy". 

 

There is no further information required to be notified under Listing Rule 9.6.13 R with regard to Mark's appointment referred to above.

 

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group +44 (0) 204 559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURAKROKUOARR
Date   Source Headline
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM
10th Apr 20249:43 amRNSDirector/PDMR Shareholding
9th Apr 20248:33 amRNSDirector/PDMR Shareholding
8th Apr 20242:15 pmRNSNotice of AGM
3rd Apr 20241:02 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:26 pmRNSTotal Voting Rights
2nd Apr 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20245:40 pmRNSDirector/PDMR Shareholding
27th Mar 20244:20 pmRNSAnnual Financial Report
27th Mar 20242:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNS2023 Annual Financial Report
6th Mar 20242:00 pmRNSDirector/PDMR Shareholding
1st Mar 20249:35 amRNSTotal Voting Rights
6th Feb 20245:17 pmRNSDirector/PDMR Shareholding
2nd Feb 202410:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNS2023 Trading Statement
8th Jan 20245:09 pmRNSDirector/PDMR Shareholding
2nd Jan 20243:15 pmRNSTotal Voting Rights
11th Dec 20236:13 pmRNSBlock listing Interim Review
6th Dec 20234:28 pmRNSDirector/PDMR Shareholding
5th Dec 202311:42 amRNSFinal Result of Tender Offer
5th Dec 202310:22 amRNSIndicative Result of Tender Offer
5th Dec 20237:10 amRNSPublication of Final Terms
1st Dec 202311:46 amRNSTotal Voting Rights
28th Nov 20235:46 pmRNSIssue of Debt and Tender Maximum Acceptance Amount
27th Nov 20238:20 amRNSTender Offers and New Issue
24th Nov 202311:05 amRNSDirector Declaration
23rd Nov 20232:00 pmRNSPublication of Supplementary Prospectus
23rd Nov 202310:00 amRNSDirectorate Change
13th Nov 20237:00 amRNSUpgrade of near-term cash generation targets
7th Nov 20235:10 pmRNSDirector/PDMR Shareholding
1st Nov 20232:07 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20231:17 pmRNSDirector/PDMR Shareholding
25th Oct 20231:16 pmRNSDirector/PDMR Shareholding
9th Oct 202312:40 pmRNSDirector/PDMR Shareholding
9th Oct 202311:20 amRNSDirector/PDMR Shareholding
4th Oct 202310:00 amRNSBoard Changes
2nd Oct 20233:00 pmRNSPublication of Supplementary Prospectus
2nd Oct 20231:35 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20232:46 pmRNSDirector/PDMR Shareholding
28th Sep 202312:49 pmRNSAvailability of Interim Financial Report
28th Sep 20237:00 amRNSInterim Financial Report
18th Sep 20237:00 amRNS2023 Interim Results
14th Sep 202310:00 amRNSHY23 reporting update
8th Sep 20239:33 amRNSDirector/PDMR Shareholding
1st Sep 20231:29 pmRNSTotal Voting Rights
9th Aug 20235:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.